Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day

by Pedersen SE, Prasad N, Goehring UM, Andersson H, Postma DS
Published 2017-03-01

Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol

by Calverley PM, Martinez FJ, Fabbri LM, Goehring UM, Rabe KF
Published 2012-06-01

Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials

by Rennard SI, Sun SX, Tourkodimitris S, Rowe P, Goehring UM, Bredenbröker D, Calverley PM
Published 2014-06-01